The US Bankruptcy Court granted an order for the joint administration of the Chapter 11 bankruptcy cases of Invitae Corporation, and its affiliates on February 16, 2024. The affiliates include Archerdx Clinical Services, Inc., ArcherDX, LLC, Genetic Solutions LLC, Genosity, LLC and Ommdom Inc. The cases would be jointly administered for administrative and procedural purposes. Invitae Corporation, has been designated as the lead debtor.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0005 USD | -94.44% | -66.67% | -99.92% |
Apr. 25 | Labcorp beats quarterly estimates on strong testing demand | RE |
Apr. 25 | Clinical lab operator Labcorp to buy bankrupt genetic test maker Invitae for $239 mln | RE |
1st Jan change | Capi. | |
---|---|---|
-99.92% | 143K | |
-20.45% | 10.82B | |
+43.17% | 3.25B | |
-35.86% | 2.11B | |
-17.21% | 2.08B | |
-29.81% | 1.48B | |
+17.56% | 1.02B | |
-4.37% | 733M | |
-37.00% | 391M | |
-46.94% | 377M |
- Stock Market
- Equities
- NVTA.Q Stock
- News Invitae Corporation
- Motion for Joint Administration Approved for Invitae Corporation